In summary, our results uncover a unique and novel metabolic regulatory axis that couples dietary fat/cholesterol to oncogenesis, and PKCβ activation may be the initial event in delaying dietary fat-induced HCC development and therefore may be an attractive therapeutic target for preventing its development. This evidence concerns the gene PRKCB and hepatocellular carcinoma.